Q1 2021 Holdings
Filed 2021-05-17 | 139 holdings | $1.0B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2021-08-13) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $477.8M | 7,756,928 | 46.2% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $116.8M | 3,158,566 | 11.3% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $103.4M | 8,703,879 | 10.0% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $68.6M | 4,697,612 | 6.6% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $40.4M | 1,143,790 | 3.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $36.4M | 1,410,305 | 3.5% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $29.4M | 797,404 | 2.8% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $29.2M | 16,584,802 | 2.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $28.0M | 3,188,750 | 2.7% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $27.1M | 409,341 | 2.6% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $23.2M | 978,277 | 2.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $16.7M | 2,153,974 | 1.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $16.4M | 650,000 | 1.6% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $14.2M | 352,804 | 1.4% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $595.2K | 3,474,505 | 0.1% |
| Retrophin Inc | NOTE 2.500% 9/1 | 761299AB2 | $474.8K | $45,000,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $356.8K | 4,849,912 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $273.9K | 8,651,785 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $225.9K | 22,861,329 | 0.0% |
| Biogen Inc(BIIB)Call | COM | 09062X103 | $209.3K | 748,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $206.1K | 5,058,642 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $204.8K | 5,360,673 | 0.0% |
| Collegium Pharmaceutical Inc | NOTE 2.625% 2/1 | 19459JAA2 | $189.6K | $17,500,000 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $188.7K | 2,050,002 | 0.0% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $184.7K | 3,109,224 | 0.0% |
| VBI Vaccines Inc CDA(VAC2USD) | COM NEW | 91822J103 | $171.2K | 55,042,465 | 0.0% |
| Biogen Inc(BIIB)Put | COM | 09062X103 | $167.9K | 600,000 | 0.0% |
| Landos Biopharma IncA | COM | 515069102 | $141.0K | 14,869,915 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $136.8K | 4,330,868 | 0.0% |
| Nevro Corp | NOTE 2.750% 4/0 | 64157FAC7 | $135.3K | $9,000,000 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $129.9K | 2,387,535 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $127.2K | 2,867,771 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $113.3K | 812,154 | 0.0% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $93.4K | 6,933,277 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $91.6K | 941,832 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $83.2K | 2,360,139 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $82.4K | 3,298,419 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $79.7K | 2,780,097 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $74.2K | 13,412,552 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $69.8K | 2,018,097 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $68.4K | 2,148,060 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $63.7K | 4,643,095 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $63.0K | 3,425,916 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $61.7K | 987,287 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $61.1K | 15,711,334 | 0.0% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $60.5K | 565,113 | 0.0% |
| Quotient LTD | SHS | G73268107 | $59.6K | 16,200,818 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $59.4K | 938,140 | 0.0% |
| Athenex Inc(ATNXEUR) | COM | 04685N103 | $57.3K | 13,532,467 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $55.4K | 3,314,032 | 0.0% |